EP 4347603 A1 20240410 - SULFUR-CONTAINING HETEROAROMATIC TRICYCLIC KRAS INHIBITORS
Title (en)
SULFUR-CONTAINING HETEROAROMATIC TRICYCLIC KRAS INHIBITORS
Title (de)
SCHWEFELHALTIGE HETEROAROMATISCHE TRICYCLISCHE KRAS-HEMMER
Title (fr)
INHIBITEURS DE KRAS TRICYCLIQUES HÉTÉROAROMATIQUES CONTENANT DU SOUFRE
Publication
Application
Priority
- US 202163192991 P 20210525
- US 202163208367 P 20210608
- US 202263327530 P 20220405
- US 2022030829 W 20220525
Abstract (en)
[origin: WO2022251296A1] The present embodiments provide compounds of Formula I, pharmaceutical compositions of the compounds, and methods for treating diseases such as cancer.
IPC 8 full level
C07D 495/04 (2006.01); A61K 31/519 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR)
A61K 31/542 (2013.01 - KR); A61K 31/554 (2013.01 - KR); A61P 35/00 (2018.01 - KR); C07D 495/04 (2013.01 - EP); C07D 513/04 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022251296 A1 20221201; AU 2022280025 A1 20231207; CA 3221390 A1 20221201; EP 4347603 A1 20240410; JP 2024520457 A 20240524; KR 20240026948 A 20240229; TW 202313633 A 20230401
DOCDB simple family (application)
US 2022030829 W 20220525; AU 2022280025 A 20220525; CA 3221390 A 20220525; EP 22731929 A 20220525; JP 2023572924 A 20220525; KR 20237044789 A 20220525; TW 111119490 A 20220525